+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neoantigen"

Drugs for Immunotherapy Market Report 2025 - Product Thumbnail Image

Drugs for Immunotherapy Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
From
From
Allogeneic T Cell Therapies Market Report 2025 - Product Thumbnail Image

Allogeneic T Cell Therapies Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
TCR Therapy Market Report 2025 - Product Thumbnail Image

TCR Therapy Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Intratumoral Cancer Therapies Market Report 2025 - Product Thumbnail Image

Intratumoral Cancer Therapies Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
Cancer Biological Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report

  • Report
  • August 2025
  • 211 Pages
  • Global
From
Neoantigen Targeted Therapies Market Report 2025 - Product Thumbnail Image

Neoantigen Targeted Therapies Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
RNA-based Therapeutics - Global Strategic Business Report - Product Thumbnail Image

RNA-based Therapeutics - Global Strategic Business Report

  • Report
  • August 2025
  • 274 Pages
  • Global
From
m-RNA Synthesis Services - Global Strategic Business Report - Product Thumbnail Image

m-RNA Synthesis Services - Global Strategic Business Report

  • Report
  • August 2025
  • 227 Pages
  • Global
From
Hyper Personalized Medicines - Global Strategic Business Report - Product Thumbnail Image

Hyper Personalized Medicines - Global Strategic Business Report

  • Report
  • August 2025
  • 390 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Neoantigen market is a subset of the Genomics market that focuses on the identification and development of neoantigens for use in cancer immunotherapy. Neoantigens are proteins that are produced by tumor cells and are recognized by the immune system as foreign, triggering an immune response. By targeting these neoantigens, cancer immunotherapy can be used to treat cancer. Companies in the Neoantigen market are focused on developing technologies to identify and develop neoantigens for use in cancer immunotherapy. Companies in the Neoantigen market include Adaptive Biotechnologies, I-Mab, Neoantigen Therapeutics, NeoVax, and OncoImmune. Show Less Read more